| CEO: | Stephen O'Hara |
| Finance Director: | David Blain |
| Non-Executive Chairman: | Neil Davidson |
| Research and Development Director: | Sofia Kolyda |
| Non-Executive Dir: | Sean Christie |
| Address: | Innovation Centre, Innovation Way, York, United Kingdom, YO10 5DG |
| Phone: | + 44 (0) 203 178 5618 |
| Website: | http://www.optibiotix.com |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BP0RTP38 |
| Currency | UK Pounds |
| Share Price | 7.58p |
| Change Today | -0.17p |
| % Change | -2.15 % |
| 52 Week High | 22.60p |
| 52 Week Low | 7.58p |
| Volume | 268,116 |
| Shares Issued | 103.30m |
| Market Cap | £7.83m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 10:57 | 30,000 @ 8.00p |
| 10:56 | 63,687 @ 8.00p |
| 09:59 | 26,586 @ 7.84p |
| 09:47 | 3,796 @ 7.84p |
| 08:43 | 100,000 @ 8.00p |
| CEO | Stephen O'Hara |
| Finance Director | David Blain |
You are here: research